Close menu
Brain & Behavior
Grants & Prizes
Home
Research
Illness
Addiction
Anxiety Disorders
Attention-Deficit Hyperactivity Disorder (ADHD)
Autism Spectrum Disorder (ASD)
Bipolar Disorder
Borderline Personality Disorder (BPD)
Depression
Eating Disorders
Mental Illness (General)
Obsessive-Compulsive Disorder (OCD)
Post-Traumatic Stress Disorder (PTSD)
Schizophrenia
Suicide Prevention
Other Brain-Related Illnesses
Category
Basic Research
New Technologies
Early Intervention/ Diagnostic Tools
Next Generation Therapies
Blog
Get Involved
Give
Donate Today
Make a Memorial/Tribute Gift
Create an Event/Memorial Page
Find an Event/Memorial Page
Make a Stock/Securities Gift/IRA Charitable Rollover Gift
Donate Cryptocurrency
Get Involved
Other Giving Opportunities
Planned Giving
Research Partners
Donor Advised Funds
Workplace Giving
Team Up for Research!
Sponsorship Opportunities
Watch
Healthy Minds TV
Meet the Scientist Webinars
Videos
Connect
Ask the Expert
Join Us
Home
Grants
Grant FAQs
BBRF Young Investigator Grants
BBRF Independent Investigator Grants
BBRF Distinguished Investigator Grants
Prizes & Awards
Klerman & Freedman Prizes
Outstanding Achievement Prizes
Lieber Prize for Schizophrenia Research
Maltz Prize for Schizophrenia Research
Colvin Prize for Mood Disorders Research
Ruane Prize for Child and Adolescent Psychiatric Research
Goldman-Rakic Prize for Cognitive Neuroscience Research
The Pardes Humanitarian Prize
Productive Lives Awards
Blog
About Us
Who We Are
Our Impact
FAQs
Media Center
News
Press Releases
Opinion Pieces
In the News
Multimedia Library
Media Kit
Events & Webinars
Team Up for Research! Events
Healthy Minds TV
Contact
Email Signup
Open Menu

Menu

What will the breakthroughs be in treatment for mood disorders in the next 5 years?

Go Back to the Questions

Q. What will the breakthroughs be in treatment for mood disorders in the next 5 years?

Husseini K. Manji, M.D.
Answer By: Husseini K. Manji, M.D.

Global Therapeutic Area Head, Neuroscience

Johnson and Johnson (J&J) Pharmaceutical Research and Development

Adjunct Professor in Psychiatry and Behavioral Sciences

Oxford University
The world of neuroscience really is exploding, and I like to say that this is a renaissance in this field. We are learning more and more about the genetics of mental health and also learning more about specific illnesses and their symptomatology, diagnosis and treatments. I believe we have great potential to treat treatment-resistant depression as well as develop antidepressants that work rapidly. Similarly, efforts are underway to try to understand “resilience pathways” that could potentially be enhanced to treat the long-term course of bipolar disorder. Unfortunately, new treatment development is very complex and often unpredictable. However, I am optimistic that we will see novel treatments coming through for mood disorders.
Tags:
Bipolar Disorder
Ask an Expert

Related Articles

Precise Imaging Reveals How a Key Receptor's Signaling Is Modulated—A Spur to Improving Psychiatric and Other Drugs

READ

Posted: Thursday, May 12, 2022

Precise Imaging Reveals How a Key Receptor's Signaling Is Modulated—A Spur to Improving Psychiatric and Other Drugs

Read more
Simple Parent Questionnaire Can Help Doctors Track Mood Symptom Trajectory in Youths at High Risk for Bipolar Disorder

READ

Posted: Thursday, March 31, 2022

Simple Parent Questionnaire Can Help Doctors Track Mood Symptom Trajectory in Youths at High Risk for Bipolar Disorder

Read more
Lumateperone, an Antipsychotic, is Tested in a Phase 3 Trial for Major Depressive Episodes in Bipolar I and II Disorders

READ

Posted: Thursday, November 4, 2021

Lumateperone, an Antipsychotic, is Tested in a Phase 3 Trial for Major Depressive Episodes in Bipolar I and II Disorders

Read more
Obesity Is a Risk Factor for Brain-Structure Changes in Schizophrenia and Bipolar Disorder, 2 Studies Show

READ

Posted: Thursday, August 12, 2021

Obesity Is a Risk Factor for Brain-Structure Changes in Schizophrenia and Bipolar Disorder, 2 Studies Show

Read more